《大行報告》美銀證券下調建行(00939.HK)目標價至6.3元 艱苦經營環境下業績穩健
美銀證券發表報告指,建行(00939.HK)上半年純利1,673億元人民幣,按年增長3.4%,較該行預期高出1.2%,核心盈利按年跌1.2%,但仍然較該行預期為佳,在艱難的經營環境有穩定業績表現。
建行上半年股東權益回報按年下跌0.7個百分點至12.1%,核心一級資本充足比率按季跌0.4個百分點至12.75%。該行將建行2023年至2025年盈利預測下調3%至7%,目標價7.05元下調至6.3元,反映今明兩年預測市盈率4.4倍。在強勁的資產負債表及防守性下,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.